✦ LIBER ✦

Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer

✍ Scribed by Fountzilas, G.; Skarlos, D.; Giannakakis, T.; Athanasiades, A.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, C.; Pavlidis, N.; Kosmidis, P.

Book ID: 122786535
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 624 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90124-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose, dose-intensive chemotherapy w

High dose, dose-intensive chemotherapy with Doxorubicin and Cyclophosphamide for the treatment of advanced breast cancer

✍ Ferguson, J.E.; Dodwell, D.J.; Seymour, A-M.; Richards, M.A.; Howell, A. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Intensive chemotherapy with high dose ep

Intensive chemotherapy with high dose epirubicin (EPI)in advanced breast cancer. the experience of the hellenic co-operative oncology group (HeCOG)

✍ Athanassiadis, A.; Skarlos, D.; Kosmidis, P.; Giannakakis, Th.; Bafaloukos, D.; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Neoadjuvant chemotherapy with standard v

Neoadjuvant chemotherapy with standard vs high dose of epirubicin plus filgrastim for locally advanced breast cancer. Report from the mexican oncology study group (MOSG)

✍ G. Morgan; C. Chan; J. Pott; L. Martignon; L. Perez-Michel; M. Ramírez; R. Zamor 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

High-dose epirubicin and r-met-hu G-CSF

High-dose epirubicin and r-met-hu G-CSF (Filgrastim) in the treatment of patients with advanced breast cancer: A hellenic cooperative oncology group study

✍ Fountzilas, George ;Skarlos, Demosthenis ;Katsohis, Constantine ;Pavlidis, Nicho 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Phase II study of high dose epirubicin i

Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer

✍ Levi, J. A. ;Tattersall, M. H. ;Beith, J. M. ;Bell, D. ;Snyder, R. D. ;Wheeler, 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Combination of Docetaxel, Epirubicin and

Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study

✍ Emilio Esteban; Antonio Modollel; Luis González de Sande; Isabel Palacio; Isabel 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 130 KB